A. E. Irvine

513 total citations
9 papers, 417 citations indexed

About

A. E. Irvine is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, A. E. Irvine has authored 9 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in A. E. Irvine's work include Cell Adhesion Molecules Research (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Cell death mechanisms and regulation (1 paper). A. E. Irvine is often cited by papers focused on Cell Adhesion Molecules Research (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Cell death mechanisms and regulation (1 paper). A. E. Irvine collaborates with scholars based in United Kingdom. A. E. Irvine's co-authors include A. L. Bell, K Williamson, Rebekah Kennedy, P A Courtney, A. D. Crockard, T. C. M. Morris, W R McKane, Susan Price, T. C. M. Morris and Z. R. Desai and has published in prestigious journals such as Annals of the Rheumatic Diseases, British Journal of Haematology and British Journal of Urology.

In The Last Decade

A. E. Irvine

9 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. E. Irvine United Kingdom 8 202 144 116 83 82 9 417
Do‐June Min South Korea 9 152 0.8× 150 1.0× 145 1.3× 61 0.7× 85 1.0× 12 458
Renate E. Gay United States 7 118 0.6× 165 1.1× 209 1.8× 48 0.6× 97 1.2× 7 497
Holger Ruchatz United Kingdom 7 367 1.8× 104 0.7× 121 1.0× 111 1.3× 130 1.6× 8 592
Belinda Baltus Netherlands 9 185 0.9× 95 0.7× 158 1.4× 44 0.5× 113 1.4× 11 409
Brandt Levitt United States 5 276 1.4× 142 1.0× 103 0.9× 68 0.8× 54 0.7× 6 451
Hanane El Bannoudi United States 11 235 1.2× 146 1.0× 165 1.4× 42 0.5× 41 0.5× 18 463
L. A. M. Van Den Bersselaar Netherlands 7 224 1.1× 167 1.2× 230 2.0× 88 1.1× 105 1.3× 9 478
Jennifer Reed United States 7 125 0.6× 105 0.7× 54 0.5× 31 0.4× 101 1.2× 13 355
Trieneke C. G. Timmer Netherlands 6 174 0.9× 68 0.5× 254 2.2× 41 0.5× 81 1.0× 8 442
Hitoshi Deguchi Japan 4 148 0.7× 70 0.5× 140 1.2× 61 0.7× 60 0.7× 5 328

Countries citing papers authored by A. E. Irvine

Since Specialization
Citations

This map shows the geographic impact of A. E. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Irvine more than expected).

Fields of papers citing papers by A. E. Irvine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. E. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Irvine. The network helps show where A. E. Irvine may publish in the future.

Co-authorship network of co-authors of A. E. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of A. E. Irvine. A scholar is included among the top collaborators of A. E. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. E. Irvine. A. E. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Crawford, Lisa, et al.. (2010). Methods for measuring proteasome activity: Current limitations and future developments. Leukemia Research. 34(11). 1403–1409. 34 indexed citations
2.
Irvine, A. E., et al.. (2008). CCN3 – A key regulator of the hematopoietic compartment. Blood Reviews. 23(2). 79–85. 31 indexed citations
3.
Lewis, John, et al.. (2008). Estimation of the accuracy of joint mobility assessment in a group of health professionals. European Journal of Orthopaedic Surgery & Traumatology. 18(4). 287–289. 3 indexed citations
4.
Courtney, P A, A. D. Crockard, K Williamson, et al.. (1999). Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Annals of the Rheumatic Diseases. 58(5). 309–314. 183 indexed citations
5.
Kelly, John D., K Williamson, A. E. Irvine, et al.. (1999). Apoptosis and its clinical significance for bladder cancer therapy. British Journal of Urology. 83(1). 1–10. 25 indexed citations
6.
Drake, Mary, T. C. M. Morris, L. Nolan, et al.. (1997). Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. British Journal of Haematology. 98(3). 745–749. 65 indexed citations
7.
Bell, A. L., et al.. (1995). Measurement of colony-stimulating factors in synovial fluid: potential clinical value. Rheumatology International. 14(5). 177–182. 41 indexed citations
8.
Bell, A. L., et al.. (1995). Human blood and synovial fluid neutrophils cultured in vitro undergo programmed cell death which is promoted by the addition of synovial fluid.. Annals of the Rheumatic Diseases. 54(11). 910–915. 23 indexed citations
9.
Irvine, A. E., et al.. (1984). Human umbilical cord conditioned medium: a stimulus for human CFU-G.. PubMed. 12(1). 19–24. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026